Comment

Comment by Animats

The New York Times has a chart, updated daily, of all the vaccines in development.[1] This is worldwide, not US.

Phase I: 24

Phase 2: 14

Phase 3: 9

Limited approval: 3 (CanSinoBio, Gamaleya Research Institute (Russia), Sinovac)

Full approval: 0

That's not even including the hundred or so still in lab or animal testing. It's encouraging; something is likely to work.

The real question is, how effective are the ones that make through the safety tests? Nobody really knows yet. The FDA (pre-Trump push) announced that their minimal effectiveness for approval was 50%, which is low for a vaccine. Moderna is aiming for 60%. Effectiveness times fraction of population getting it has to be > 70% or so to stop the epidemic with a vaccine alone. That's the "herd immunity" fraction for a disease with a growth rate of 3.

Useful questions:

- If a vaccine is only partially effective, will an antibody test tell if it worked?

- Will taking one vaccine limit the effectiveness of another vaccine taken later? That's happened for a few vaccines.[2] It's usually more of a timing thing; some vaccines should not be given within a few weeks of other vaccines.[3]

- Could widespread use of a moderately effective vaccine cause people to abandon mask-type precautions and cause an epidemic spike in the unprotected part of the population?

Is someone working those issues effectively?

[1] https://www.nytimes.com/interactive/2020/science/coronavirus...

[2] https://www.tandfonline.com/doi/pdf/10.1080/21645515.2015.10...

[3] https://www.ok.gov/health2/documents/IMM_PRG_5-20_Intervals_...

parent Animats 6 years ago

Discussion

Live from the official Hacker News API

A modern reader for Hacker News · SvelteKit + Skeleton